Butyrate
Sponsors
Maastricht University Medical Center, Federico II University, KU Leuven, University of Padova, Children's Hospital Los Angeles
Conditions
EmotionsFearInflammatory Bowel DiseasesInsulin ResistanceIrritable Bowel SyndromeObesityObesity &Amp; OverweightObesity, Childhood
Phase 2
The Effects of Butyrate on Children With Obesity
NCT02721953
Start: 2016-03-31End: 2018-03-31Target: 40Updated: 2016-03-30
The Use of Butyrate Therapy in Pediatric Ulcerative Colitis
RecruitingNCT05218850
Start: 2022-06-29End: 2027-06-30Target: 10Updated: 2026-06-04
Dietary Supplements to Treat Radiation-Induced Rectal Injury
RecruitingNCT06776016
Start: 2025-01-15End: 2026-12-31Target: 33Updated: 2026-08-07
Unknown Phase
The Effects of Butyrate Enemas on Visceral Perception
CompletedNCT00726817
Start: 2007-12-31Updated: 2017-02-24
*Effects of Butyrate on Intestinal permeability & inflammation, Intellectual performance, Immune activation and systemic Inflammation in renal disease.
NL-OMON43237
Target: 30Updated: 2024-02-28
Effects of Butyrate Against Pediatric Obesity
CompletedNCT04620057
Start: 2020-11-01End: 2021-12-31Updated: 2022-04-08
Effects of Butyrate on Affective Processes
CompletedNCT04722549
Start: 2021-02-08End: 2022-12-11Updated: 2023-01-04
Analysis of Microbiota Changes Induced by Microencapsulated Sodium Butyrate in Patients With Inflammatory Bowel Disease
CompletedNCT04879914
Start: 2020-06-01End: 2022-09-30Updated: 2022-11-03
Effects of Administration of SCFA in Rheumatoid Arthritis Inadequate Responders
CompletedNCT05718583
Start: 2023-02-01End: 2025-02-20Updated: 2026-09-02
Can Gut Bacteria Predict Who Benefits Most From Exercise? A Gut Supplement to Help Exercise Non-Responders
Active, not recruitingNCT07180446
Start: 2026-01-18End: 2026-06-30Target: 40Updated: 2026-05-27
Sodium Butyrate and Kluyveromyces Marxianus Supplementation in Inflammatory Bowel Disease
RecruitingNCT07591012
Start: 2026-05-01End: 2027-03-30Target: 40Updated: 2026-05-15
Butyrate or Intensive Lifestyle Modification in Type 1 Diabetes and Metabolic Dysfunction-Associated Steatotic Liver Disease
Not yet recruitingNCT07684248
Start: 2026-09-15End: 2028-02-15Target: 200Updated: 2026-07-06